Clinical benefit for minority patients (pts) with advanced refractory cancer versus non Hispanic whites (NHW) when enrolled on early phase (I) clinical trials.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18634
Abstract: e18634Background: Minority pts have poor representation in clinical trial participation, and little data exists specifically about phase I trials. These represent a valuable option for pts with adv... read more here.
Keywords: clinical benefit; minority; pts advanced; patients pts ... See more keywords